Evidence map›Paper›PMID 33860151›Full record

ArticleJNCI cancer spectrum2021

DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology Settings.

Wynne E Norton, Worta McCaskill-Stevens, David A Chambers, Philip J Stella, Otis W Brawley, Barnett S Kramer

Abstract read
In one paragraph

Article in JNCI cancer spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wynne E NortonDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0002-9895-8078
Worta McCaskill-StevensDivision of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0002-0487-7526
David A ChambersDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
Philip J StellaSt Joseph Mercy Hospital, Ann Arbor, MI, USA.
Otis W BrawleyEpidemiology, Bloomberg School of Public Health Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0001-7384-1853
Barnett S KramerDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0002-4972-3950

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients, practitioners, and policy makers are increasingly concerned about the delivery of ineffective or low-value clinical practices in cancer care settings. Research is needed on how to effectively deimplement these types of practices from cancer care. In this commentary, we spotlight the National Cancer Institute Community Oncology Research Program (NCORP), a national network of community oncology practices, and elaborate on how it is an ideal infrastructure for conducting rigorous, real-world research on deimplementation. We describe key multilevel issues that affect deimplementation and also serve as a guidepost for developing strategies to drive deimplementation. We describe optimal study designs for testing deimplementation strategies and elaborate on how and why the NCORP network is uniquely positioned to conduct rigorous and impactful deimplementation trials. The number and diversity of affiliated community oncology care sites, coupled with the overall objective of improving cancer care delivery, make the NCORP an opportune infrastructure for advancing deimplementation research while simultaneously improving the care of millions of cancer patients nationwide.

Indexed as

Comparative Effectiveness ResearchOutcome Assessment, Health CareProgram EvaluationCommunity Health ServicesHealth Services ResearchHumansMedical OncologyMedical OveruseNational Cancer Institute (U.S.)NeoplasmsUnited States

Identifiers

PMID33860151
PMCPMC8036997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.